PAI-039, a small molecule inhibitor of PAI-1 that was investigated clinically for treatments of acute and arterial thrombosis [38], has been tested for its efficacy in preclinical tumor angiogenesis mouse models [39]. The gene discussed is SERPINE1; the disease is neoplasm.